Vivien Wong serves as Executive at PROGENICS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Vivien Wong has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 16, 2024 involved receiving (via award) 7,937 shares valued at $0.
Vivien Wong currently holds 24,568 shares of PROGENICS PHARMACEUTICALS INC (PGNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Vivien Wong has been a net neutral trader of PGNX stock. They have purchased $0 and sold $0 worth of shares.
Vivien Wong's most recent insider trade was on Aug 16, 2024, when they sold 7,937 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 13, 2024 | CYTH | $0 | Award | 6,330 | $N/A | Discretionary |
| Nov 28, 2023 | CYTH | $0 | Award | 2,488 | $N/A | Discretionary |
| Jun 19, 2020 | PGNX | $0 | Disposition | 4,121 | $N/A | Discretionary |